Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFUL.L Regulatory News (FUL)

  • There is currently no data for FUL

Collaboration with Quantum Solutions

14 Nov 2008 07:00

RNS Number : 1344I
Fulcrum Pharma PLC
14 November 2008
 



FULCRUM PHARMA PLC 

Fulcrum Pharma and Quantum Solutions India form strategic collaboration to deliver high quality, high capacity drug safety services 

Fulcrum Pharma plc (AIM: FUL), the Professional Services company is pleased to announce a strategic collaboration with Quantum Solutions India in the field of drug safety. 

Fulcrum Pharma is committed to providing clients with expert solutions in pharmacovigilance for both pre- and post-marketed products. The collaboration brings together Fulcrum Pharma's expertise in strategic and operational pharmacovigilance and Quantum's expertise in delivering high quality ICSR and PSUR processing. 

The two companies will offer creative pharmacovigilance solutions in a cost-effective and tailored approach to new and existing clients. Quantum and Fulcrum Pharma believe that together they are positioned to deliver effective safety solutions to clients using a cost-leadership model coupled with excellence in execution and a proven track record in quality & compliance. 

Under the terms of the collaboration the companies will pool expertise and resources and establish a joint sales and marketing campaign in Europe and North America. Both companies, however, remain legally and operationally independent. 

Speaking of the newly forged strategic collaboration, Frank Armstrong, Chief Executive of Fulcrum Pharma, said: "Together we will be in a position to meet the increasing demand for pharmacovigilance services. The collaboration with Quantum will increase our capacity to deliver key safety products to our clients and enhance the reach of our business. We look forward to working together to develop solutions for our clients." 

Apurva Goswamy, Chief Executive of Quantum Solutions, said. "This collaboration will provide tailored solutions to meet our customers' needs, combining the strategic and operational skills of Fulcrum Pharma with the operational expertise of Quantum Solutions. Working with Fulcrum Pharma will enable us to enhance our drug safety product offering in a way that directly benefits our clients. This is an exciting opportunity for both Quantum and Fulcrum" 

For further information, please contact: 

Fulcrum Pharma PLC

Dr Frank M. Armstrong, Chief Executive  Tel: 01442 283600

Dr Phil Birch, General Manager (Europe) Tel: 01442 283600

About Fulcrum Pharma plc 

Fulcrum Pharma plc is a professional services company providing clients with expert solutions for the development of therapeutic products. Fulcrum Pharma is listed on the AIM Market of the London Stock Exchange having successfully floated in March 2000. 

About Quantum Solutions India

Quantum Solutions India is a highly-reputed quality-driven contract research organization serving the pharmaceutical industry, and specializing in drug safety. Its highly qualified, professional, English-speaking staff supported by a robust IT infrastructure ensure very high standards of service delivery.

___________________________

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAILFEELVLVLIT
Date   Source Headline
11th Apr 202312:00 pmRNSForm 8.5 (EPT/RI)
11th Apr 202312:00 pmRNSForm 8.5 (EPT/RI) - The Fulham Shore Plc
11th Apr 202310:20 amRNSForm 8.3 - The Fulham Shore PLC
6th Apr 20233:57 pmRNSForm 8.3 - Fulham Shore Plc
6th Apr 202312:13 pmGNWForm 8.3 - [The Fulham Shore plc - Opening Declaration - 05 04 2026] - (CGAML)
6th Apr 202312:00 pmRNSForm 8.5 (EPT/RI) - The Fulham Shore Plc
6th Apr 202310:43 amRNSForm 8.5 (EPT/RI)
5th Apr 20234:51 pmRNSForm 8.3 - The Fulham Shore plc
5th Apr 20232:40 pmRNSForm 8.3 - Fulham Shore Plc
5th Apr 202312:47 pmRNSForm 8.3 - The Fulham Shore PLC
5th Apr 202312:43 pmRNSForm 8.3 - FULHAM SHORE PLC/THE
5th Apr 202311:10 amBUSForm 8.3 - The Fulham Shore PLC
5th Apr 20237:30 amRNSTrading Update
5th Apr 20237:30 amRNSRecommended Offer for The Fulham Shore PLC
29th Mar 20237:00 amRNSExercise of options and total voting rights
10th Mar 20233:35 pmRNSHolding(s) in Company
3rd Jan 20234:10 pmEQSHardman & Co Research on The Fulham Shore (FUL): Resilient first-half trading
16th Dec 20229:05 amRNSSecond Price Monitoring Extn
16th Dec 20229:00 amRNSPrice Monitoring Extension
16th Dec 20227:00 amRNSHalf-year Report
7th Dec 202211:05 amRNSSecond Price Monitoring Extn
7th Dec 202211:00 amRNSPrice Monitoring Extension
2nd Dec 20224:29 pmRNSHolding(s) in Company
1st Nov 20227:00 amRNSBusiness Development & Trading Update
31st Aug 20224:23 pmRNSResult of AGM
31st Aug 20227:00 amRNSAGM Statement & Trading Update
23rd Aug 202210:10 amEQSHardman & Co Interview on: The Fulham Shore Plc (FUL) Full ahead
9th Aug 20229:30 amRNSPublication of Annual Report & Notice of AGM
1st Aug 202212:32 pmEQSHardman & Co Research: The Fulham Shore (Initiation of coverage): Platform ready for take-off
21st Jul 20227:00 amRNSFinal Results
8th Jun 20227:00 amRNSTrading Update and Notice of Final Results
4th Apr 20227:00 amRNSTrading Update
21st Jan 202212:00 pmRNSExercise of Options & Total Voting Rights
18th Jan 20226:10 pmRNSExercise of Options & Total Voting Rights
13th Jan 20225:38 pmRNSHolding(s) in Company
13th Jan 202212:30 pmRNSExercise of Options and Total Voting Rights
11th Jan 202212:45 pmRNSExercise of Options and Total Voting Rights
7th Jan 20225:27 pmRNSExercise of Options and Total Voting Rights
29th Dec 20218:43 amRNSPDMR Dealing
6th Dec 202112:05 pmEQSHardman & Co Research: The Fulham Shore (FUL) - Investor Forum company research (Nov 2021)
6th Dec 20217:00 amRNSHalf-year Report
2nd Dec 20211:00 pmRNSNotice of Interim Results
1st Dec 20217:00 amRNSTotal Voting Rights
8th Nov 20214:50 pmRNSChange of Registrar
8th Nov 20212:18 pmEQSHardman & Co Research : Hardman & Co Video Event | The Fulham Shore plc - Investor Forum
5th Nov 20216:08 pmRNSExercise of Options and Total Voting Rights
4th Nov 20217:00 amRNSTrading Update
3rd Nov 20214:40 pmEQSHardman & Co Video Event | The Fulham Shore plc Investor Forum
29th Oct 20214:30 pmRNSTotal Voting Rights
7th Oct 20215:18 pmRNSExercise of Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.